Vanillyl mandelic acid excretion in unilateral electroconvulsive therapy (ECT).
The twenty-four hour urinary excretion of vanillyl mandelic acid was determined in a group of eleven psychiatric patients prior to and during the day of the fifth unilateral electroconvulsive treatment. The patients were all determined by their treating psychiatrists and by psychological testing to be psychotically depressed. In ten of the eleven patients a marked decrease in excreted vanillyl mandelic acid was apparent from the pretreatment level to the fifth treatment level. In one of the eleven patients there was a slight rise from the pretreatment level to the excreted level during the fifth day of treatment. The mean pretreatment determination of vanillyl mandelic acid was 4.2 mg per twenty-four hours; the mean determination made on the fifth treatment was 2.8 mg per twenty-four hours.
D003863:Depression / Q000150:complications / Q000628:therapy / Q000652:urine; D004565:Electroconvulsive Therapy; D007839:Functional Laterality; D006801:Humans; D011618:Psychotic Disorders / Q000150:complications / Q000628:therapy / Q000652:urine; D014642:Vanilmandelic Acid / Q000652:urine*
D014642:Vanilmandelic Acid